Journal
JOURNAL OF ECONOMETRICS
Volume 122, Issue 2, Pages 213-246Publisher
ELSEVIER SCIENCE SA
DOI: 10.1016/j.jeconom.2003.09.002
Keywords
entry of innovative drugs; barriers to entry; structural diffusion models
Ask authors/readers for more resources
We specify and estimate a diffusion model for the new molecule omeprazole into the anti-ulcer drug market. Our model is based on a Bayesian teaming process whereby doctors update their beliefs about omeprazole's quality relative to existing drugs after observing its effects on the patients that have been prescribed this drug. The model also accommodates informational spillovers and heterogeneity in informativeness across patients with different diagnoses. We obtain estimates of the teaming process parameters using a novel panel data set tracking doctors' complete prescription histories over a 3-year period. (C) 2003 Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available